Press Releases

< 2021 >

Filter:

April 22, 2021
Genocea To Host First Quarter 2021 Corporate Update Conference Call & Webcast
CAMBRIDGE, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical compa...
April 10, 2021
Genocea to Present Novel Preclinical Inhibigen™ Data at AACR Annual Meeting 2021
Pro-tumor effects detected as early as four days after Inhibigen administration Insights into Inhibigen biology may yiel...
April 6, 2021
Genocea to Present at the 20th Annual Needham Virtual Healthcare Conference
CAMBRIDGE, Mass., April 06, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical compa...
March 2, 2021
Genocea to Present at the H.C. Wainwright Global Life Sciences Conference
CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical compa...
February 11, 2021
Genocea Provides Fourth Quarter 2020 Corporate Update
GEN-011 and GEN-009 clinical trials continue to advance ATLAS TM stimulatory antigen and inhibitory antigen (Inhibigen T...
February 4, 2021
Genocea to Host Fourth Quarter 2020 Corporate Update Conference Call & Webcast
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical compan...
January 28, 2021
Genocea Announces Publication in Cancer Discovery Highlighting the Advantages of Neoantigen Identification with the ATLAS™ Platform
Study validates ATLAS bioassay for developing patient-specific cancer immunotherapies by including neoantigens of anti-t...
January 19, 2021
Genocea to Participate in the B. Riley Securities’ Virtual Oncology Investor Conference
CAMBRIDGE, Mass. , Jan. 19, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical compa...
January 4, 2021
Genocea to Present at the H.C. Wainwright Virtual BioConnect Conference
CAMBRIDGE, Mass. , Jan. 04, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc.  (NASDAQ: GNCA), a biopharmaceutical comp...